In Profile – Elizabeth Seaquist
Daniella Otway of the Diabetic Hypoglycemia Editorial Team
Diabetic Hypoglycemia January 2014, Volume 6, Issue 3: page 15-17
Elizabeth Seaquist is a professor of medicine at the University of Minnesota Medical School in the USA, where she holds the Pennock Family Chair in Diabetes Research. She is a clinical investigator interested in hypoglycemia and the complications of diabetes. Her research focuses on the effect of diabetes on brain metabolism, structure, and function. She has been funded by the National Institutes of Health (NIH) for more than 15 years and was awarded a Distinguished Clinical Scientist Award by the American Diabetes Association (ADA) in 2009. Dr Seaquist also directs the University of Minnesota sites for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial and the Glycemia Reduction Approaches for Diabetes: A Comparative Effectiveness (GRADE) Study. She is the principal investigator on the NIH training grant for fellows in endocrinology and diabetes at the University of Minnesota, and has an active clinical practice. A member of the ADA since 1987, Dr Seaquist has served at the national level on the Research Policy Committee, the Research Grant Review Committee, the Legislative Advocacy Subcommittee, the Scientific and Health Care Award Committee, the 2010–2015 Strategic Planning Committee, and the Scientific Sessions Meeting Planning Committee. She is currently President of Medicine and Science. Dr Seaquist is board-certified in Internal Medicine and Endocrinology, Diabetes, and Metabolism. She holds a Bachelor of Arts degree from Vassar College in Poughkeepsie, New York, and a Medical Doctorate from the University of Minnesota in Minneapolis.